1.Li M#, Yang X, Zhang G, Wang L, Zhu Z, Zhang W, Huang H, Gao R*. Heterogeneous nuclear ribonucleoprotein K promotes the progression of lung cancer by inhibiting the p53-dependent signaling pathway. Thorac Cancer. 2022 May;13(9):1311-1321.（IF=3.5）
2.Zhang W#, Chen X, Ding D, Zhang G, Zhu Z, Yang X, Li M, Liang L, Shi X, Wang T, Gao R*. Real-time in vivo imaging reveals specific nanoparticle target binding in a syngeneic glioma mouse model. Nanoscale. Nanoscale, 2022, 14, 5678 - 5688.（IF=7.790）
3.Cao L#, Huang T, Chen X, Li W, Yang X, Zhang W, Li M, Gao R*. Uncovering the interplay between pH receptors and immune cells: Potential drug targets (Review). Oncol Rep. 2021 Oct;46(4):228. doi: 10.3892/or.2021.8179. Epub 2021 Sep 3. PMID: 34476504. （IF=3.906）
4.Cao L#, Li W, Yang X, Zhang W, Li M, Zhang H, Qin C, Chen X*, Gao R*. Inhibition of host Ogr1 enhances effector CD8+ T-cell function by modulating acidic microenvironment. Cancer Gene Ther. 2021 Nov;28(10-11):1213-1224.（IF=5.927）
5.Shi X*, Gao K, Xiong S, Gao R*. Multifunctional Transferrin Encapsulated GdF3 Nanoparticles for Sentinel Lymph Node and Tumor Imaging. Bioconjug Chem. 2020 Nov 18;31(11):2576-2584. （IF=4.031）
6.Sun S#, Li K, Lei Z, Xiao L, Gao R*, Zhang Z*. Immunomodulatory activity of polysaccharide from Helicteres angustifolia L. on 4T1 tumor-bearing mice. Biomed Pharmacother. 2018 May;101:881-888.（IF=3.457）
7.Shi X#, Gao K, Huang H, Gao R*. Pretargeted Immuno-PET Based on Bioorthogonal Chemistry for Imaging EGFR Positive Colorectal Cancer. Bioconjug Chem. 2018 Feb 21;29(2):250-254.（IF=4.485）
8.Huang H#, Han Y, Yang X, Li M, Zhu R, Hu J, Zhang X, Wei R, Li K, Gao R*. HNRNPK inhibits gastric cancer cell proliferation through p53/p21/CCND1 pathway. Oncotarget. 2017 Oct 17;8(61):103364-103374.（IF=5.168）
9.Wei R*, Li B, Guo J, Li M, Zhu R, Yang X, Gao R*. Smurf1 targets Securin for ubiquitin-dependent degradation and regulates the metaphase-to-anaphase transition. Cell Signal. 2017 Oct;38:60-66.（IF=3.937）
10.Wei R*, Guo J, Li M, Yang X, Zhu R, Huang H, Li K, Zhang L, Gao R*. Smurf1 controls S phase progression and tumorigenesis through Wee1 degradation. FEBS Lett. 2017 Apr;591(8):1150-1158.（IF=3.623）
微信公众号
京公网安备11010502033649